Skip Navigation

Targeted portfolio

A unique portfolio of high quality and difficult-to-make pharmaceutical products fuels our targeted growth strategy. We offer high-quality, affordable generic medications that help reduce healthcare costs around the world.

Product catalog

Our product portfolio consists of a broad range of leading molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory medicine, neurology and gastroenterology. We focus on niche generics, transdermal patches, controlled release, and first to file and first to market products.


An experienced team of professionals from the generics and brand industry has built a strong profitable base and infrastructure for our generic and brand business in the U.S..

Product formulations manufactured and sold by Alvogen include solid oral dosage, soft gelatin capsules, modified release tablets, transdermals, creams, ointments and injectables.


Almaject® Inc. is a wholly owned subsidiary of Alvogen, specializing in the commercialization of generic injectable pharmaceuticals for the acute and alternate site healthcare markets in the US.


Alvogen currently has an extensive OTC (over-the-counter) portfolio, offering an innovative approach to everyday health problems. Our range covers the main OTC categories: Food supplements, OTC medicines, cosmetics and medical devices.

We seek out products that offer something new to the consumer, focusing on patented technology with clinically proven efficacy, along with staple OTC products necessary in every household, such as painkillers, antihistamines and ointments. Our OTC strategy centers around comprehensive solutions based on unique target market segmentation and value added properties, such as taste, delivery form or ingredient composition.

Branded portfolio

Alvogen is focused on the acquisition, development and commercialization of brand named Rx products through its subsidary Almatica Pharma. Almatica has a current product portfolio that includes pain, anti-infective, cardiovascular and psychiatry related therapies.

Our business model ensures competitive advantage by having broad in-house capabilities and a network of partners for enhanced speed and flexibility.

Commited to quality


Alvogen's operations includes manufacturing facility in the Norwich, New York, US. Capabilities include finished dosage form manufacturing including solid oral dosage, soft gelatin capsules, modified release tablets, transdermals, creams, ointments and injectables.

Patients safety

Our goal is to ensure that the benefits and risks of a medication are continuously monitored and well-understood by regulators, healthcare providers and patients. Alvogen maintains a pharmacovigilance system, collecting information over the lifecycle of each product.

Local teams

Alvogen is headquartered in Morristown, New Jersey with significant inhouse manufacturing capacity in Norwich, NY. Alvogen is built on the strong foundation of Norwich Pharmaceutical Services, an U.S. company with a 130-year history and an unsurpassed regulatory track record.